newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026

SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at